甲基受体2在乳腺癌抗阿德里亚米辛的功能
Landi Su1, Jingjing Li1, Li Qin1
1School of Medicine, Yangzhou Polytechnic College, Yangzhou, Jiangsu, China.
Experimental biology and medicine (Maywood, N.J.)
|January 30, 2025
概括
甲基类受体2 (FPRL2) 在乳腺瘤中升高,与预后不佳和阿德里亚米辛耐药性有关. 沉默FPRL2增强了乳腺癌细胞中的阿德里亚米辛敏感性和亡.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 生物信息学是一种生物信息学.
背景情况:
- 类似于2的甲基受体 (FPRL2) 与各种癌症有关,但它在乳腺癌和化学抵抗中的作用尚未得到充分研究.
- 了解FPRL2的功能对于开发针对乳腺癌的向治疗至关重要.
研究的目的:
- 调查FPRL2在乳腺癌进展和阿德里亚米辛耐药性的作用.
- 分析FPRL2表达,患者预后和化学敏感性之间的相关性.
主要方法:
- 对TCGA和GEO数据库进行FPRL2表达和患者预后的生物信息分析.
- 利用DepMap工具评估FPRL2对阿德里亚米辛敏感性的影响.
- 进行了CCK-8测定,流细胞计和西部斑分析,以评估化学敏感性,亡和蛋白质表达 (p-ERK5,p-AKT).
主要成果:
- 与正常组织相比,乳腺瘤组织中的FPRL2表达显著高于正常组织,与患者预后不佳相关.
- 在耐氨酸乳腺癌患者中观察到FPRL2水平升高.
- 沉默FPRL2降低了阿德里亚米的IC50值,增加了亡,并降低了p-ERK5和p-AKT的表达.
结论:
- 在乳腺癌中,FPRL2在调解阿德里亚米辛耐药性方面发挥着重要作用.
- 击败FPRL2增强了乳腺癌细胞的亡,增加了对阿德里亚米的敏感性,这表明FPRL2是潜在的治疗标.
相关概念视频
02:38Mitogens and the Cell Cycle
6.4K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.4K
02:56Treatment Resistant Cancers
3.2K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.2K
02:57Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
02:23Abnormal Proliferation
4.4K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.4K
01:15Receptor Downregulation in MVBs
2.0K
Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
2.0K
01:27Transducer Mechanism: Enzyme-Linked Receptors
2.3K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
2.3K